Abstract
African histoplasmosis is a rare but not an exceptional condition and recently discovered in Madagascar. We report the fifth Malagasy case involving skin and nodes in an immunocompetent patient. Management of African histoplasmosis encountered many problems because of the availability of amphotericin B and cost of the biochemical tests in order to prevent major side effects in case of failure of oral antimycotic drug.
MeSH terms
-
Adult
-
Amphotericin B / administration & dosage
-
Amphotericin B / adverse effects
-
Antifungal Agents / administration & dosage
-
Antifungal Agents / adverse effects
-
Fatal Outcome
-
Histoplasma / isolation & purification
-
Histoplasmosis / diagnosis*
-
Histoplasmosis / drug therapy
-
Histoplasmosis / microbiology
-
Humans
-
Immunocompetence*
-
Lymph Nodes / microbiology
-
Madagascar
-
Male
-
Skin / microbiology
Substances
-
Antifungal Agents
-
Amphotericin B